Cipta Sarana Medika Tbk. vs Sinergi Multi Lestarindo Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 24.02M 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp144 (market cap 298B, 13.54M 24h volume). The key difference: Sinergi Multi Lestarindo Tbk. is the larger of the two by market cap, and Cipta Sarana Medika Tbk. is more actively traded (24.02M versus 13.54M). Which is the better fit depends on your goals.
| DKHH | SMLE | |
|---|---|---|
Market Cap | 160.67B | 298B |
Volume | 24.02M | 13.54M |
Lot | 240.19K | 135.37K |
Turnover | 1.56B | 1.83B |
Average Price | 65 | 135.02 |
Value | 1.56B | 1.83B |
Indicative Equilibrium Price | 64 | 144 |
Indicative Equilibrium Volume | 1.67K | 1.56K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →